Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the drug interaction potential and time course of the
effect of oritavancin on warfarin pharmacokinetics in an open label, single arm manner.